Skip to main content

Month: January 2024

Refinancing of bond loan

12 January 2024Announcement no. 359 Refinancing of bond loan Following the announcement on 30 December 2023, that Rovsing was in the process of securing new financing to the Company by a combination of new capital and new bond loan and where the first step was finalized on 9 January (Announcement 358) with a share issue of 85.714 new shares, which provided DKK 2.999.990 in proceeds. Today, the Company can announce the next step in strengthening the capital structure, with the signature of an agreement for a new loan with a lender for DKK 2.200.000. The new loan is with the following terms:A loan of DKK 2.200.000 with a term of 24 months. 12% annual interest with quarterly accrual of interest. The loan is non-cancellable for the lender, but the lender can convert the loan into shares, however in the first 12 months with a cap of 8.570...

Continue reading

Polylactic Acid Market Set to Soar Past USD 3.11 Billion by 2030

The global Polylactic Acid market size is expected to reach USD 3.11 billion by 2030 and exhibit a CAGR of 6.42% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increased consumer awareness and demand for sustainable and eco-friendly packaging materials, growing emphasis on reducing plastic waste and environmental concerns, government regulations promoting biodegradable plastics, the rising use of PLA in various applications like packaging, textiles, and medical devices, and the ongoing research and development efforts to enhance PLA’s performance characteristics are fueling the market’s growth. Westford,USA, Jan. 12, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Polylactic Acid market, increased investment in PLA production capacity...

Continue reading

Nine Mile Metals Receives Bulk Sample Project Permit Approval for Its High-Grade Lens Bulk Sample Project at Nine Mile Brook

Figure 1Rusty Rhyolite Cap, Nine Mile Brook Lens (Bulk Sample Project Area)Figure 2Massive Copper, Lead, Zinc, Silver, Gold Lens Ore, Nine Mile Brook Lens BulkVANCOUVER, British Columbia, Jan. 12, 2024 (GLOBE NEWSWIRE) — NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), is pleased to announce it has received Final Approval of its Nine Mile Brook Lens Bulk Sample Permit from the NB Department of Mines Resource Development Branch (NB DEM), for the Nine Mile Brook Lens Bulk Sample Project.Nine Mile Metals has received Final NB DEM Bulk Sample Permit Approval Nine Mile Metals has now initiated its Vendors Award and Confirmation process Nine Mile Metals can now implement its Program Cost-Budget Analysis Nine Mile Metals can now begin scheduling the Bulk Sample Excavation Project...

Continue reading

Greenridge Exploration Announces Listing on the Frankfurt Stock Exchange under the Symbol HW3

VANCOUVER, British Columbia, Jan. 12, 2024 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP) (FSE: HW3), is pleased to announce its common shares are now trading on the Frankfurt Stock Exchange (“FSE”) under the symbol “HW3”, WKN: A3EXGV and ISIN: CA 3949191041. The Company’s common shares are now cross listed on the Canadian Stock Exchange and the FSE, providing international exposure to both Canadian and European investors. The dual listing will also provide additional liquidity for the Company’s shareholders. The Company’s FSE stock quote link can be found here: https://www.boerse-frankfurt.de/equity/greenridge-expl-inc. Greenridge Exploration CEO, Russell Starr, commented, “We are thrilled to be listed on one of the world’s largest trading markets. The Company is confident that the inclusion...

Continue reading

Talkspace to Present at the 26th Annual Needham Growth Conference

NEW YORK, Jan. 12, 2024 (GLOBE NEWSWIRE) — Talkspace (Nasdaq: TALK), a leading behavioral healthcare company, today announced that management will present and host one-on-one investor meetings at the 26th Annual Needham Growth Conference on January 16 and 19, 2024, virtually. The Company’s presentation will be on January 19, 2024, at 3:00pm EST. To schedule a one-on-one meeting with management, please contact your Needham representative. About Talkspace Talkspace (Nasdaq: TALK) is a leading virtual behavioral healthcare company committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall healthcare and should be available to everyone. Talkspace pioneered the ability to text with a licensed therapist from anywhere and...

Continue reading

Collective Metals Submits Notice of Work for 2024 Exploration Program on its Princeton Project

Figure 1Princeton Project Proposed Year 1 Work Program Including Proposed Diamond Drill Hole LocationsHighlights:Application for 5-year Multi-Year Area-Based (“MYAB”) permit for diamond drilling on up to 50 sites in the southern portion of the Princeton Project (the “Property”) Proposed 10 drill sites to test multiple targets along 3.3 km of Trojan-Condor corridor for Year 1 Ground-based induced polarization (“IP”) proposed on several additional targets in north and south portions of PropertyVANCOUVER, British Columbia, Jan. 12, 2024 (GLOBE NEWSWIRE) — COLLECTIVE METALS INC. (CSE: COMT | OTC: CLLMF | FSE: TO1) (the “Company” or “Collective”) has submitted three Notices of Work to the South-Central B.C. regional office of the Ministry of Energy, Mines, and Low Carbon Innovation (EMLI), located in Kamloops. The applications...

Continue reading

CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference

SOUTH SAN FRANCISCO, Calif., Jan. 12, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in a fireside chat at the B. Riley Securities Virtual Annual Oncology Investor Conference on Thursday, January 18, 2024 at 1:00 p.m. ET. To access this event, please reach out to your B. Riley Securities sale representative for a recording of the fireside chat. About CytomX TherapeuticsCytomX is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. By pioneering a novel pipeline of localized biologics, powered by its Probody®...

Continue reading

Vortex Energy Announces Results of Shareholder Meeting

All matters placed before the meeting, including the re-election of the Company’s directors, the approval of the Company’s equity incentive plan and the amendment of the quorum requirement in the Company’s articles, were passed VANCOUVER, British Columbia, Jan. 12, 2024 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FRA: AA3) (“Vortex” or the “Company“) announces the voting results from its Annual General and Special Meeting of shareholders held on January 11, 2024 (the “Meeting”). A total of 24,260,177 (representing 34.21% of the issued and outstanding common shares) were represented at the Meeting. The three nominees listed in the management information circular with respect to the Meeting were elected as directors of the Company. Shareholders also approved the Company’s equity incentive plan...

Continue reading

Ardelyx, Inc. Reports Employment Inducement Grants

WALTHAM, Mass., Jan. 12, 2024 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on January 10, 2024, the compensation committee of the company’s board of directors granted two new non-executive employees options to purchase an aggregate of 23,580 shares of the company’s common stock, and granted three new non-executive employees an aggregate of 33,300 Restricted Stock Units (RSUs). Each stock option has an exercise price equal to $9.08 per share, which was the closing trading price of the company’s common stock on the date of grant. The stock options and RSUs were granted as inducements material to each employee’s decision to enter into employment...

Continue reading

NXT Announces Closing of Private Placement of Convertible Debentures

CALGARY, Alberta, Jan. 12, 2024 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX: SFD; OTCQB: NSFDF) is pleased to announce the closing of the private placement of convertible debentures that was previously announced on November 9, 2023 (the “Debentures”) for a total of US$1,872,000 (approximately CAD$2,542,000). The Debentures are convertible into common shares in the capital of NXT (the “Common Shares”) at a conversion price of US$0.1808 (approximately CAD$0.25) per Common Share, which provides the subscribers with the right to obtain an aggregate of up to 10,353,982 Common Shares. Any Common Shares issued upon the conversion of the respective Debentures will be subject to a hold period of four months plus a day from the date of issuance of the Debenture being so converted. Insiders...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.